News Image

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - KYTX

Provided By PR Newswire

Last update: Feb 4, 2025

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. ("Kyverna" or the "Company") (NASDAQ: KYTX).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Read more at prnewswire.com

KYVERNA THERAPEUTICS INC

NASDAQ:KYTX (8/1/2025, 8:00:02 PM)

3.44

-0.13 (-3.64%)



Find more stocks in the Stock Screener

Follow ChartMill for more